secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001193125-25-017223
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm shareholders approve reverse stock split and share increase
----------------------------------------------------------------------

- Approved increase in authorized capital stock to 805M shares (common to 800M).
- Approved reverse stock split at ratio 1:5 to 1:15; board to decide timing and exact ratio by Feb 28, 2025.
- Reverse split: 74.8M votes for, 20.0M against; share increase: 71.6M for, 23.4M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312525017223/0001193125-25-017223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312525017223/d893335d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-017223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer